Fredun Pharmaceuticals Ltd - 539730 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations
We inform that the Members of the Company in the 33rd Annual General Meeting held on 28th September, 2020, have approved the re-appointment of Dr. (Mrs.) Daulat Medhora, Joint Managing Director of the Company for further period of 3 years with effect from 1st January, 2021. Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and 'Code of Conduct for Prevention of Insider Trading' of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the trading window for dealing in securities of the Company will remain closed for designated persons and their immediate relatives with effect from Friday, 1st January, 2021 till 48 hours after the end of the Board Meeting wherein; the approval of Un-audited Financial Results for the Quarter ended 31st December, 2020, would be considered, approved and declared. Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
The Company hereby informs that we have issued Duplicate Share Certificate to the below mentioned Shareholder, in lieu of his old share certificate on 12th December, 2020. Name of Shareholder - Mr. Tushar Jayantilal Bhuta Jt Holder Mrs. Sonal Tushar Bhuta Number of Shares- 1500 Distinctive Nos- 0000236701 to 0000238200 Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance to Regulation 47(1)(b) of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter and Half Year ended September 30, 2020; as approved by the Board in its Meeting held on Monday, November 09, 2020; published in Business Standard & Mumbai Lakshadeep newspaper(s) on Wednesday, November 11, 2020. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance to Regulation 47(1)(b) of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter and Half Year ended September 30, 2020; as approved by the Board in its Meeting held on Monday, November 09, 2020; published in Business Standard & Mumbai Lakshadeep newspaper(s) on Wednesday, November 11, 2020. Fredun Pharmaceuticals Ltd - 539730 - Outcome Of Board Meeting Held On 9Th November, 2020
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Monday, 9th November, 2020 at 3:00pm; had considered and approved the following items of Business: 1. In compliance to Regulation 30 and 33 of SEBI Listing Regulations, 2015; the Un-Audited Financial Results of the Company and the Cash Flow Statement for the Second Quarter and Half Year ended 30th September, 2020; along with the Limited Review Report as issued by M/s. Savla & Associates; Statutory Auditors of the Company Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Fredun Pharmaceuticals Limited has informed BSE regarding loss of Share Certificate/ Issue of Duplicate Share Certificate. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance to Regulation 47 of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Notice of the ensuing Board Meeting of the Company scheduled to be held on Monday, November 09, 2020 at 3:00 P.M.; published in Business Standard & Mumbai Lakshadeep newspapers on Tuesday, 27th October, 2020. Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Unaudited Financial Results Of The Company For The Quarter And Half-Year Ended 30Th September, 2020
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI Listing Regulations, 2015; we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 9th November 2020 at 3:00 P.M. at the Registered Office of the Company interalia to discuss, consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2020; Fredun Pharmaceuticals Ltd - 539730 - Half Yearly Certificate Under Regulations 40(9) & 40(10) Of SEBI Listing Regulations, 2015
In compliance to Regulation 40(9) & 40(10) of SEBI Listing Regulations, 2015; we furnish hereunder the certificate for the half year ended September 30, 2020 of Fredun Pharmaceuticals Limited as issued by Rajendra & Co., Practising Company Secretaries.